Dr. Birgit Ritter studied biology at the Friedrich-Schiller University in Jena. In 2010 she started her PhD in the lab of Falk Nimmerjahn at the University of Erlangen, investigating the role of effector cells in antibody-dependent melanoma therapy. After continuing as a postdoc to work on antibody therapy in colitis, she joined the Greten lab… [mehr]